SCHEMBL14033906

SCHEMBL14033906

CCCC[C@H]1CN(C(c2ccc(F)cc2)c2ccc(F)cc2)CCN1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.43
DPP4 P27487 1/20 0.43
ACHE P22303 3/20 0.39
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
SLC6A2 P23975 4/20 0.35
SLC6A4 P31645 3/20 0.35
SLC6A3 Q01959 4/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
CHRM1 P11229 1/20 0.34
CYP2D6 P10635 3/20 0.34
MEN1 O00255 2/20 0.34
MAPK1 P28482 2/20 0.34
THPO P40225 2/20 0.34
KMT2A Q03164 2/20 0.34
IGF1R P08069 1/20 0.34
KCNH2 Q12809 1/20 0.34
GMNN O75496 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16226979 1.00 HRH3 (0.43) HRH3DPP4ACHEOPRM1OPRD1
SCHEMBL14033868 0.87 CYP2D6 (0.49) HRH3DPP4OPRM1OPRD1SLC6A2
SCHEMBL26673752 0.87 HRH3 (0.46) HRH3ACHEOPRM1OPRD1SLC6A2
SCHEMBL6874564 0.84 HRH3 (0.42) HRH3ACHEOPRM1OPRD1SLC6A2
SCHEMBL27048362 0.81 HRH3 (0.43) HRH3ACHEOPRM1OPRD1SLC6A2
SCHEMBL21831282 0.81 HRH3 (0.43) HRH3ACHEOPRM1OPRD1SLC6A2
SCHEMBL27048103 0.81 HRH3 (0.43) HRH3ACHEOPRM1OPRD1SLC6A2
Hydrochloric Acid SCHEMBL27033977 0.80 HRH3 (0.43) HRH3ACHEOPRM1OPRD1SLC6A2
Hydrochloric Acid SCHEMBL27130665 0.80 HRH3 (0.43) HRH3ACHEOPRM1OPRD1SLC6A2
Hydrochloric Acid SCHEMBL27033984 0.80 HRH3 (0.43) HRH3ACHEOPRM1OPRD1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
EP-1423381-B1 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES SCHERING CORP (US) 2007-01-03 EP disclosed